Table of Contents
Volume 2 | Issue 2
Publication Date: September 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
71 |
Clinical Prostate Cancer in Year Two: New and Promising Therapies for Treatment and Possible Prevention of Prostate Cancer Oliver Sartor |
|
Meeting Highlights | ||
73-79 |
Highlights from: The 39th Annual Meeting of the American Society of Clinical Oncology; Chicago, Illinois; May 31–June 3, 2003 Preeta Tyagi, Jennifer Klem, Amy D’Orazio, Oliver Sartor |
|
Researches in Brief | ||
81-83 |
Autologous Dendritic Cells Pulsed with Prostatic Acid Phosphatase (APC8015) for Patients with Hormone-Refractory Prostate Cancer with a Gleason Score ≤ 7 David Lee, Oliver Sartor, Vinay K. Jain |
|
84-86 |
Clinical Trials of Atrasentan in Hormone-Refractory Prostate Cancer David Lee, Oliver Sartor |
|
Comprehensive Reviews | ||
87-97 |
Population Screening for Prostate Cancer and Emerging Concepts for Young Men Judd W. Moul |
|
98-105 |
Intensity-Modulated Radiation Therapy for Prostate Cancer Ashesh B. Jani, John C. Roeske, Carla Rash |
|
106-110 |
Active Surveillance with Selective Delayed Intervention: A Biologically Nuanced Approach to Favorable-Risk Prostate Cancer Laurence Klotz |
|
Original Contributions | ||
111-114 |
Salvage Cryosurgery for Recurrent Prostate Cancer After Radiation Therapy: A Seven-Year Follow-up Duke K. Bahn, Fred Lee, Paul Silverman, Eric Bahn, Robert Badalament, Anil Kumar, Jeffrey Greski, John C. Rewcastle |
|
115-118 |
Characterization of Prostate Cancer Missed by Sextant Biopsy John B. Bak, Steve K. Landas, Gabriel P. Haas |
|
Translational Medicine | ||
119-126 |
The Role of Cyclooxygenase-2 Inhibition for the Prevention and Treatment of Prostate Carcinoma Daniel W. Lin, Peter S. Nelson |
|
Brief Communication | ||
127-128 |
The Clinical Rationale for Immediate Androgen Deprivation Without Estrogen Deprivation W. Reid Pitts, Jr |
|